Based: Blacksburg, VA
Investors: New River Management funds, managed by Third Security and NewVa Capital Partners, and other investors.
Scoop: To fund its modular DNA control systems, Intrexon closed another round of Series D financing, enlisting the help of 65 investors in the process. And after raising another $1 million this month, the company has nearly $130 million to continue working on its technology. The company also recently acquired a North Carolina biotech, Agarigen, for its mushroom-based expression platform for the rapid, high yield production of recombinant proteins.